NO910263D0 - Fremgangsmaate for fremstilling av di- og tetra-fluoranaloger av skualen. - Google Patents

Fremgangsmaate for fremstilling av di- og tetra-fluoranaloger av skualen.

Info

Publication number
NO910263D0
NO910263D0 NO910263A NO910263A NO910263D0 NO 910263 D0 NO910263 D0 NO 910263D0 NO 910263 A NO910263 A NO 910263A NO 910263 A NO910263 A NO 910263A NO 910263 D0 NO910263 D0 NO 910263D0
Authority
NO
Norway
Prior art keywords
tetra
fluor
analogues
school
procedure
Prior art date
Application number
NO910263A
Other languages
English (en)
Other versions
NO910263L (no
Inventor
Esa Tero Jarvi
Michael Louis Edwards
James Ray Mccarthy
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO910263D0 publication Critical patent/NO910263D0/no
Publication of NO910263L publication Critical patent/NO910263L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C21/00Acyclic unsaturated compounds containing halogen atoms
    • C07C21/02Acyclic unsaturated compounds containing halogen atoms containing carbon-to-carbon double bonds
    • C07C21/215Halogenated polyenes with more than two carbon-to-carbon double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
NO91910263A 1990-03-30 1991-01-23 Fremgangsmaate for fremstilling av di- og tetra-fluoranaloger av skualen. NO910263L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/502,203 US5011859A (en) 1990-03-30 1990-03-30 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase

Publications (2)

Publication Number Publication Date
NO910263D0 true NO910263D0 (no) 1991-01-23
NO910263L NO910263L (no) 1991-10-01

Family

ID=23996803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910263A NO910263L (no) 1990-03-30 1991-01-23 Fremgangsmaate for fremstilling av di- og tetra-fluoranaloger av skualen.

Country Status (19)

Country Link
US (1) US5011859A (no)
EP (1) EP0448934B1 (no)
JP (1) JP2911239B2 (no)
KR (1) KR0162659B1 (no)
CN (1) CN1055172A (no)
AT (1) ATE118756T1 (no)
AU (1) AU629726B2 (no)
CA (1) CA2034612C (no)
DE (1) DE69107488T2 (no)
ES (1) ES2071131T3 (no)
FI (1) FI910425A (no)
HU (1) HU208103B (no)
IE (1) IE910181A1 (no)
IL (1) IL97356A0 (no)
NO (1) NO910263L (no)
NZ (1) NZ236800A (no)
PH (1) PH27365A (no)
PT (1) PT96654A (no)
ZA (1) ZA91392B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7238394A (en) * 1993-07-29 1995-02-28 Chugai Seiyaku Kabushiki Kaisha Tricarboxylic acid derivative having squalene synthetase inhibitor activity
DE19754795A1 (de) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CL2007002958A1 (es) * 2006-10-12 2008-05-09 Epix Delaware Inc Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
US20100331298A1 (en) * 2007-12-10 2010-12-30 Cytopathfinder, Inc. Carboxamide Compounds and Their Use
EP2280766A1 (en) 2007-12-11 2011-02-09 CytoPathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
US20130072519A1 (en) 2010-05-21 2013-03-21 Edward Lee Conn 2-phenyl benzoylamides
EP2680874A2 (en) 2011-03-04 2014-01-08 Pfizer Inc Edn3-like peptides and uses thereof
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JP7128969B2 (ja) 2019-01-18 2022-08-31 アストラゼネカ・アクチエボラーグ Pcsk9阻害剤及びその使用方法
CN112678833B (zh) * 2020-11-17 2023-08-04 广西中烟工业有限责任公司 纳米二氧化硅改性角鲨烯有机硅颗粒及其制备和使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876672A (en) * 1972-02-21 1975-04-08 Du Pont Hydroformylation of olefins
DE2913677C2 (de) * 1979-04-05 1983-03-03 Union Rheinische Braunkohlen Kraftstoff AG, 5000 Köln Verfahren zur Herstellung von Acetaldehyddimethylacetal
US4455441A (en) * 1982-09-24 1984-06-19 Research Foundation Of State University Of New York Attractant termiticidal compounds, compositions and methods of use therefor
DE3618115A1 (de) * 1986-05-30 1987-12-03 Bayer Ag Halogenolefine
US4876295A (en) * 1987-03-11 1989-10-24 The Dow Chemical Company Flexible thermoplastic epoxy resin and coatings prepared therefrom

Also Published As

Publication number Publication date
ES2071131T3 (es) 1995-06-16
CA2034612C (en) 2001-05-15
PH27365A (en) 1993-06-21
CN1055172A (zh) 1991-10-09
EP0448934B1 (en) 1995-02-22
EP0448934A2 (en) 1991-10-02
FI910425A (fi) 1991-10-01
NZ236800A (en) 1993-05-26
US5011859A (en) 1991-04-30
IL97356A0 (en) 1992-05-25
AU6946891A (en) 1991-10-03
HUT56533A (en) 1991-09-30
NO910263L (no) 1991-10-01
AU629726B2 (en) 1992-10-08
HU208103B (en) 1993-08-30
EP0448934A3 (en) 1991-11-27
DE69107488D1 (de) 1995-03-30
JP2911239B2 (ja) 1999-06-23
JPH04221327A (ja) 1992-08-11
ATE118756T1 (de) 1995-03-15
FI910425A0 (fi) 1991-01-29
KR910016660A (ko) 1991-11-05
KR0162659B1 (ko) 1999-01-15
HU910174D0 (en) 1991-08-28
CA2034612A1 (en) 1991-10-01
PT96654A (pt) 1991-10-31
ZA91392B (en) 1991-10-30
DE69107488T2 (de) 1995-06-14
IE910181A1 (en) 1991-10-09

Similar Documents

Publication Publication Date Title
NO910263D0 (no) Fremgangsmaate for fremstilling av di- og tetra-fluoranaloger av skualen.
DE69225128D1 (de) Verfahren zur Aufbereitung von sich berührendem und degradiertem Text
DE4290881T1 (de) Verfahren zur Massage der Wirbelsäulengegend
IT1232889B (it) Composizioni e procedimento per il trattamento ammorbidente di tessuti
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
ZA847193B (en) Benzothiophene derivatives as antiasthmatic agents
DE69306915D1 (de) Kombination zur Detektion von Weichgewebeanomalien
DE59404497D1 (de) Verfahren zur Herstellung von tertiären Dialkylpolyhydroxyaminen
DE59103046D1 (de) Verfahren zur Herstellung von Alkylglycosiden und Alkylpolyglycosiden.
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
ES2169037T3 (es) Conjugados polietilenglicol-hirudina, su procedimiento de preparacion y su empleo para el tratamiento de las trombosis.
DE59206781D1 (de) Verfahren zur Herstellung von Isocyanaten und Aufarbeitung des Rückstandes
DE4291487T1 (de) Verfahren zur Herstellung von 4-Isothiazolin-3-on
DE69131769D1 (de) Verfahren zur Herstellung von Ethylbenzol
DE69218196D1 (de) Cholesterinsenkende tocopherolanaloga
ATA211586A (de) Heilbehelf zur reposition des augenhoehlenbodens
DE59302483D1 (de) Verfahren zur Herstellung von cycloaliphatischen Aminen
DK139685A (da) Liposomer med inhalative allergener til behandling af allergier, fremgangsmaade til deres fremstilling og laegemidler indeholdende disseliposomer
DE19675009I2 (de) Verfahren zur Herstellung von Hylan und Hylanverbindungen.
DE69220448D1 (de) Verfahren zur Herstellung von Cumarin und Derivaten davon
GR3005231T3 (no)
DE59203788D1 (de) Verfahren zur Herstellung und Reinigung von 1-Amino-2-phenoxy-4-hydroxy-anthrachinon.
DK0741746T3 (da) Thymosin alpha 1-analoger
ATE72979T1 (de) Zusammenstellung zur behandlung der osteoporose beim menschen.
IT1233937B (it) Berrettino parasole, realizzabile in materiale in foglio, opportunamente fustellato, in modo da consentire una facile ed originale ripiegatura dello stesso.